“I think what makes us very unique is that if we put our heads together and do it 100%, we can do it and we will get it done,” says Oliver Hennig, SVP Product Supply, about #TeamBiontech’s spirit. With this drive, we aspire to become an innovation leader in vaccine development and cancer precision medicine.
Since joining BioNTech in 2015, Oliver has worked on building and expanding our manufacturing and supply chain network to ensure our #therapy candidates and #vaccines reach those who need them most. During Project Lightspeed in 2020 and 2021, he was involved in building our commercial-scale manufacturing capabilities, which enabled us to successfully produce COVID-19 vaccine doses for worldwide distribution. Together with his teams, he is currently preparing commercial-scale manufacturing for potential future cancer therapies.
Ещё видео!